Navigation Links
KLRI Receives Grant From NIH to Study Stress Resilience in Older Adults
Date:8/6/2008

Study to help determine if physical fitness increases the body's ability to recover from mental and oxidative stress in healthy men and women

PHOENIX, Aug. 6 /PRNewswire-USNewswire/ -- The Kronos Longevity Research Institute (KLRI) has been awarded a research grant from the National Institutes of Health (NIH) to conduct research on oxidative stress resilience and its effects on seniors. Previous studies have discovered that older individuals suffer dramatically poorer outcomes [compared to young individuals] when exposed to acute stressors such as illness, injury, exertion or surgery.

The scope of the study will focus on three elements:

1. Determine the effects of physical fitness on oxidative stress resilience.

2. Determine the effects of physical fitness on neuroendocrine stress reactivity, as assessed by measurements of the pituitary-adrenal axis response to a validated psychosocial laboratory stressor, comparing fit and unfit older men and women.

3. Investigate relationships and correlations between intra-individual responses to a defined oxidative stressor and a controlled psychosocial stress stimulus.

Participants in this study will be healthy men and women who are over 60, non-smokers and who do not have a history of high blood pressure, cardiovascular problems or clinical depression.

About the Kronos Longevity Research Institute (KLRI)

KLRI, a not-for-profit 501(c) (3) organization, is a leader in developing new modes of prevention and treatment to enhance human longevity. KLRI is the only independent research institute devoted exclusively to translating basic discoveries in the process of aging into useful tools, improved medical care and healthier lives. KLRI's research is conducted by its own highly regarded scientists and through collaborations with some of the nation's leading medical research centers. Because KLRI conducts pioneering research in an area of science that is poorly understood,
'/>"/>

SOURCE Kronos Longevity Research Institute
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Eniva USA Efacor(R) Fish Oil (Non-Fishy Lemon Taste) Receives ConsumerLab.com Seal of Approval
2. University of South Florida receives new multimillion award to assess juvenile diabetes treatments
3. Lupin Receives USFDA Approval for Divalproex Sodium Delayed-Release Tablets
4. Tianyin Pharmaceutical Co., Inc. Receives Chinese SFDA Approval for Simvastatin Tablets
5. Go Healthy Receives Letter of Recognition From the Texas Chiropractic Association
6. Eagle Ventures Subsidiary Hydrate2O Receives 2008 Top Gear of the Year Award From ShapeYou.com
7. Escalon(R) Receives FDA 510(k) Clearance to Market the LIASYS(TM) Clinical Chemistry and Immunoturbidimetric Analyzer
8. French Agency Receives 10 Million Dollar Grant From the Bill & Melinda Gates Foundation to Support the Establishment of National Vaccine Advisory Committees in Africa and Asia
9. Pandemic research receives $1.6M funding boost
10. Mt. Sinai's Children's Trauma Institute Treatment and Service Adaptation Center Receives Video Conferencing Donation From IVCi
11. Greater Medical Center Group Receives Major Funding From MELCO Investments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)...HASSEE, Fla. -- A Florida State University College...s discovered an important new layer of regulation ...greater understanding of the way cancer begins. ,...ces at the College of Medicine, said the findings ...r and could lead to the design of new drugs that k...
(Date:11/21/2008)... Colo., Nov. 21 Heska Co...ll present at the New York Society of,Security An...onference on,December 2, 2008 at 1177 Avenue of t...ntation is scheduled to begin at 9:35 a.m. Eastern...able via live webcast and for two weeks,following...
(Date:11/21/2008)...rchers remain cautious about future antibiotic res..., Nov. 21 (HealthDay News) -- People with moderate...COPD) may be able to reduce the frequency of exace...ntibiotic, a new report says. , The study, pub...rican Journal of Respiratory and Critical Care Med...
(Date:11/21/2008)...Nov. 21 The University... beginning of a collaborative effort to eradicate ...r Breast Cancer Awareness and Research of the Amer...Lady of the United States, and Vivian Fernandez de...ining M. D. Anderson in the initiative are the U.S...
Breaking Medicine News(10 mins):Health News:Long-Term Erythromycin Cut COPD Complications 2Health News:First Lady Laura Bush's Partnership for Breast Cancer Awareness and Research Extends to Panama 2Health News:First Lady Laura Bush's Partnership for Breast Cancer Awareness and Research Extends to Panama 3
...transvaginal ultrasound scans can do away with inv... tests, used for determining// a woman’s success r...Kwee from Vrije Universiteit Medical Center in Ams...e ovaries of women subjects in an IVF program. ...
...re consuming very little of vegetables and fruits ...d other ailments//. This was disclosed by Heidi Bl... Blanck found that 32.6% of the respondents had fr...umed vegetables thrice or more than thrice per day...
...health caused by an unintentional injury or new ch...likely to have difficulty// obtaining recommended ...declines in short-term health, according to a stud...nstitute, Washington, D.C., presented the results ...
...rary of Science) suggests that computers could gue...lating// the wishes of a terminally sick patient. ...tumbled upon this finding while he was analyzing t...ne on the course of action involving a critically ...
Other Medicine News:Health News:Cheaper and Quicker Alternative to Ovarian Reserve Tests 2Health News:Uninsured Often Receive Less Medical Care 2
(Date:11/19/2008)...on Payment from Roche- , , MONTVALE, N.J., ...ticals Corp. (Nasdaq: MEMY ) today announced tha...e 2 trial of R3487/MEM 3454, its lead alpha-7 nico...sociated with schizophrenia (CIAS). The Company h...riggering a $5.0 million payment from its partner ...
(Date:11/18/2008)...v. 18 Forty-two leading...vember national forum to consider cutting-edge inn...nd national economy from outbreaks of dangerous zo..., , Among those innovations: , , , ...tchen table that detects highly contagious and dan...
(Date:11/13/2008)...ests Nutritional Supplements Prior to Surgery, AR...ire/ -- Identifying,malnutrition before surgery in...ing will significantly decrease surgical complicat...ty and boost patient energy levels,according to a...tructive,Surgery(R), the official medical journal ...
(Date:11/12/2008)...o and LOD, Israel, November 12 Sur...r, NY indicated that,patient-specific CTA data can...Mentor(TM), Simbionix US) with high face validity....n improved the operative flow,increased patient s...overall operative and fluoroscopy time and the amo...
Breaking Medicine Technology:Memory Pharmaceuticals Achieves Enrollment Goal for Phase 2 Study of MEM 3454 in Cognitive Impairment Associated With Schizophrenia 2Memory Pharmaceuticals Achieves Enrollment Goal for Phase 2 Study of MEM 3454 in Cognitive Impairment Associated With Schizophrenia 342 Top U.S. Scientists and Specialists Explore Cutting-Edge Innovations to Defend America From Dangerous Zoonotic Diseases 2Plastic Surgeons Warn of Malnutrition in Body Contouring Patients 2Vascular Surgeons Agree: Case Rehearsal Improves Outcomes 2Night Hospitalist Company LLC Launches First Nighttime Hospitalist Telemedicine Solution 22612 1Night Hospitalist Company LLC Launches First Nighttime Hospitalist Telemedicine Solution 22612 2URAC Releases Standards and Measures for Wellness Programs for Public Comment 22608 1URAC Releases Standards and Measures for Wellness Programs for Public Comment 22608 2URAC Releases Standards and Measures for Wellness Programs for Public Comment 22608 3URAC Releases Standards and Measures for Wellness Programs for Public Comment 22608 4URAC Releases Standards and Measures for Wellness Programs for Public Comment 22608 5New Generation Biofuels Set to Join Russell Microcap Index 6178 1New Generation Biofuels Set to Join Russell Microcap Index 6178 2New Generation Biofuels Set to Join Russell Microcap Index 6178 3Pressure BioSciences Inc Announces 24850 000 NIH SBIR Phase II Award for the Development of a New PCT dependent System for Improved Biomarker Disco 2509 1Pressure BioSciences Inc Announces 24850 000 NIH SBIR Phase II Award for the Development of a New PCT dependent System for Improved Biomarker Disco 2509 2Pressure BioSciences Inc Announces 24850 000 NIH SBIR Phase II Award for the Development of a New PCT dependent System for Improved Biomarker Disco 2509 3Pressure BioSciences Inc Announces 24850 000 NIH SBIR Phase II Award for the Development of a New PCT dependent System for Improved Biomarker Disco 2509 4
...sitive Phase IIa Clinical,Trial Results, First cli... Key,Product in AM-Pharma,s Pipeline , BUNNIK, The...pharmaceutical company developing novel therapeuti...today announced the positive,clinical results of i...atients with ulcerative colitis, a chronic and rel...
...nc. (NASDAQ:INSM), a ,biopharmaceutical company fo... the treatment of metabolic diseases with unmet,m...t at this,week,s C.E. Unterberg, Towbin (CEUT) Eme...City. , The conference, to be held at the Manda...m Tuesday, July 10th through Thursday,July 12th. ...
Other Medicine Technology:AM-Pharma Announces Positive Results of Phase IIa Clinical Trial,with Alkaline Phosphatase For Ulcerative Colitis 2AM-Pharma Announces Positive Results of Phase IIa Clinical Trial,with Alkaline Phosphatase For Ulcerative Colitis 3AM-Pharma Announces Positive Results of Phase IIa Clinical Trial,with Alkaline Phosphatase For Ulcerative Colitis 4AM-Pharma Announces Positive Results of Phase IIa Clinical Trial,with Alkaline Phosphatase For Ulcerative Colitis 5Insmed Inc. to Present at C.E. Unterberg, Towbin Growth Conference 2
...erior Chamber Lenses: The Bausch & Lomb PMMA Poste... used for primary implantation for the visual corr...lder where a cataractous lens has been removed by ... intended to be placed in the ciliary sulcus or ca...
Single-Piece PMMA IOLs for the replacement of the human crystalline lens in the visual correction of aphakia.
Multipiece PMMA IOL - Sulcus Fixation.
Single-Piece PMMA IOLs for the replacement of the human crystalline lens in the visual correction of aphakia.
Medicine Products: